Jaiwant Rangi, MD, FACEEndocrinologist | Founder, Lower The Dose® | Speaker

Thinning Down Without Getting Healthy

28 Jun 2026 · 0 min

Watch on YouTube

0:27

Dr. Jaiwant Rangi warns that GLP-1 drugs like Ozempic and Mounjaro cause rapid weight loss but don't reduce inflammation or other cardiovascular risks, and often trigger muscle loss. He says you need clear health goals before starting them, not just the number on the scale.

One more thing I want to add here is the Ozempic craze or the Mounjaro craze. So many people are losing weight with that and they think they're fixing their metabolic health. It's just part of the equation. It's not addressing your inflammation. It's not addressing your risks. You're losing so much muscle mass. So don't try to cut short. You need to understand what your risk is before you start taking these medications. And we need to have a goal, what we're trying to achieve.

More from Jaiwant

0:38

Unlocking the Unique Biology Behind the Six Faces of Diabetes

1mo ago

0:36

Unlocking the Diabetes Mystery: Why the Same Lab Results Lead to Entirely Different Realities

1mo ago

0:46

Decoding Diabetes: Moving Beyond Labels to Personalized Medicine

1mo ago

0:33

The Misdiagnosed Diabetic: Unmasking the Slow Decline of LADA

1mo ago

0:35

Unbraking the Body: Understanding Insulin Resistance versus Deficiency

1mo ago

0:35

Misdiagnosed and Mismanaged: The High Cost of Mistaking Type 1 Diabetes for Type 2

1mo ago

0:38

Fueling the Body: Understanding the Spectrum of Insulin Deficiency and Resistance

1mo ago

0:43

The Hidden Danger of Metabolic Disease in Normal-Weight Individuals

1mo ago

0:48

Decoding the Diagnosis: Navigating the Critical Pathways of Diabetes Reversal and Remission

1mo ago

0:46

Asking the Right Questions: Taking Control of Your Medical Diagnosis

1mo ago

0:36

The Interconnected Crisis: Why Modern Medicine Must Treat the Whole Patient

1mo ago

See all content